The Cancer Informatics Shared Resource (CISR), a newly reorganized Shared Resource of the Masonic Cancer Center (MCC), provides MCC members with state-of-the-art bioinformatics and clinical informatics services, providing cutting-edge methods, tools, infrastructure, and expert consultations and collaborations to cancer researchers. During the previous period, the Clinical and Translational Science Institute (CTSI) and Institute for Health Informatics (IHI), in consultation with the MCC, recruited Dr. Constantin Aliferis to be the Clinical Research Informatics Officer for the UMN. Under Dr. Aliferis' leadership, health informatics at the UMN has expanded rapidly, leading to organizational restructuring and faculty recruitments. Dr. Aliferis shared the vision witn MCC leadership of integrating Bioinformatics with Medical Informatics. Thus, CISR was created by integrating the MCC's BioInformatics consultation service and the cancer clinical informatics services, formerly known as Oncology Medical Informatics Services (OMIS), with the Institute for Health Informatics the Bioinformatics Consultation Services, while maintaining a cancer-focused informatics subgroup in IHI. This strategic integration will greatly expand the cancer informatics capacity for analyzing large-scale datasets by leveraging the expanded informatics resources the UMN including several high-impact informatics methods development labs, a full range of educational activities (including degree programs and specialized courses), informatics support of high-throughput assays, a secure data environment, and a clinical trial management system. CISR will build upon the past informatics successes to expand and strengthen cancer bioinformatics research development, increase the reach of its consulting service, guide the development of clinical genome informatics, and develop system-wide processes to integrate clinical and genomic data to support translational and clinical research for personalized oncology. In 2016, Professor Jinhua Wang, PhD, a noted computational biologist with a research interest in high- throughput cancer genomics projects, was recruited to Direct CISR. Also new is his direct report, Assistant Professor Ahmad AbuSalah, PhD, who leads the cancer informatics consultation services. Two key Bioinformatics staff, Drs. Aaron Sarver and Nuri Alpay Temiz, were promoted to IHI faculty when CISR formed, and are working closely with Dr. Wang to enhance bioinformatics collaborations and consulting. CISR provides consultation services and expertise critical to the clinical research mission of the MCC in five major areas: 1) cancer genomics and clinical data science and analytics; 2) clinical and genomics data sharing, infrastructure integration, and method development; 3) development of methods for analyzing new genomics technology; 4) education and training on big-data analytics and precision oncology; and 5) clinical trial data management infrastructure and grant data integration. In addition to supporting the administrative needs of the MCC, CISR supports significant database applications used by the Translational Therapy Laboratory (MSC- LIMS) and the Clinical Trials Office (OnCore).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA077598-21
Application #
9631654
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-02-01
Budget End
2020-01-31
Support Year
21
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Ma, Bin; Zarth, Adam T; Carlson, Erik S et al. (2018) Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol 31:48-57
Hatsukami, Dorothy K; Luo, Xianghua; Jensen, Joni A et al. (2018) Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA 320:880-891
Lee, Hak Rae; Leslie, Faith; Azarin, Samira M (2018) A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2. J Biol Eng 12:12
Yang, Libang; Herrera, Jeremy; Gilbertsen, Adam et al. (2018) IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity. Am J Physiol Lung Cell Mol Physiol 314:L127-L136
Regan Anderson, Tarah M; Ma, Shihong; Perez Kerkvliet, Carlos et al. (2018) Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Mol Cancer Res 16:1761-1772
Grzywacz, Bartosz; Moench, Laura; McKenna Jr, David et al. (2018) Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control. J Immunother :
Santiago, Victor; Lazaryan, Aleksandr; McClune, Brian et al. (2018) Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome. Leuk Lymphoma 59:958-966
Guo, Jingshu; Villalta, Peter W; Weight, Christopher J et al. (2018) Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry. Chem Res Toxicol :
Boatman, Jeffrey A; Vock, David M; Koopmeiners, Joseph S et al. (2018) Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics 19:103-118
Rashidi, Armin; Shanley, Ryan; Yohe, Sophia L et al. (2018) Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples. Br J Haematol 182:887-894

Showing the most recent 10 out of 1013 publications